Q-omics provides the consensus-scored OR4F29 profile across patient tissues and cancer cell-line models. Additionally, OR4F29 RNA expression shows 59 significant protein co-abundance associations, with the highest sampling consensus in BRCA.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for OR4F29 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with OR4F29 in patient tissues and cancer cell lines. In patient samples, OR4F29 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set. In cancer cell lines, OR4F29 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Lymphoma.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	59	BRCA (59)	view →
Function (mass-spec)	29	BRCA (29)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	4,087	BLOOD_Lymphoma (1637)	view →
Function (RNA)	1,230	BLOOD_Lymphoma (432)	view →